Michael R Narkewicz Selected Research

Michael R Narkewicz Research Topics

Disease

12	Infections 01/2020 - 05/2006
12	Liver Diseases (Liver Disease) 01/2019 - 08/2003
9	Chronic Hepatitis C 01/2020 - 10/2006
8	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 08/2003
8	Acute Liver Failure (Fulminant Hepatic Failure) 11/2018 - 01/2006
5	Fibrosis (Cirrhosis) 12/2018 - 11/2005
4	Biliary Atresia 03/2016 - 09/2003
3	Hepatitis C 01/2020 - 08/2010
2	Portal Hypertension 01/2019 - 11/2009
2	Inflammation (Inflammations) 11/2013 - 03/2008
2	Hepatitis 12/2009 - 09/2003
2	Hypertension (High Blood Pressure) 11/2009 - 07/2005
2	Chronic Hepatitis B 11/2009 - 09/2004
2	Cholestasis 10/2005 - 07/2002
1	Cough 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Vomiting 01/2020
1	Fever (Fevers) 01/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 11/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2018
1	Bronchitis 01/2018
1	Hemorrhage 01/2018
1	Obstructive Sleep Apnea 01/2018
1	Meconium Ileus 01/2017
1	Pancreatitis 01/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2013
1	Hepatic Encephalopathy 04/2013
1	Headache (Headaches) 03/2013
1	Autoimmune Diseases (Autoimmune Disease) 03/2013
1	Hypothyroidism 03/2013
1	Autoimmune Hepatitis 03/2013
1	Weight Loss (Weight Reduction) 08/2012
1	Neonatal hemochromatosis 11/2011
1	Congenital Hepatic Fibrosis 05/2011
1	Alagille Syndrome (Alagille-Watson Syndrome) 05/2011
1	Rectal Prolapse 10/2010
1	Prolapse 10/2010
1	Premature Obstetric Labor (Premature Labor) 08/2010
1	Uveitis 08/2010
1	Neoplasms (Cancer) 12/2009
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2009
1	Macrophage Activation Syndrome 12/2009
1	Hepatopulmonary Syndrome 11/2009
1	End Stage Liver Disease 02/2009
1	Bruton type agammaglobulinemia 02/2009
1	Overweight 03/2008
1	Spontaneous Perforation 11/2006
1	Brain Diseases (Brain Disorder) 05/2006
1	Metabolic Diseases (Metabolic Disease) 05/2006

Drug/Important Bio-Agent (IBA)

7	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 10/2006
5	InterferonsIBA 03/2013 - 09/2004
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2006
3	Antiviral Agents (Antivirals)IBA 01/2020 - 10/2006
3	AutoantibodiesIBA 01/2017 - 09/2003
2	TabletsIBA 01/2020 - 12/2018
2	Ritonavir (Norvir)FDA Link 01/2020 - 11/2018
2	paritaprevirIBA 01/2020 - 11/2018
2	ombitasvirIBA 01/2020 - 11/2018
2	sofosbuvir drug combination ledipasvirIBA 01/2020 - 12/2018
2	dasabuvirIBA 01/2020 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 01/2017
2	EnzymesIBA 01/2017 - 04/2010
2	BilirubinIBA 03/2016 - 05/2013
2	Alanine Transaminase (SGPT)IBA 11/2013 - 03/2008
2	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2013 - 05/2006
1	ChloridesIBA 01/2022
1	elexacaftorIBA 01/2022
1	ivacaftor drug combination tezacaftorIBA 01/2022
1	SolutionsIBA 01/2020
1	ledipasvirIBA 12/2018
1	SofosbuvirIBA 12/2018
1	Clostridium perfringens epsilon-toxinIBA 05/2018
1	Insulin (Novolin)FDA Link 01/2018
1	PlasticsIBA 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2017
1	Antinuclear AntibodiesIBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2016
1	Kazal Pancreatic Trypsin InhibitorIBA 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2013
1	AntibodiesIBA 03/2013
1	Interleukin-2 Receptor alpha SubunitIBA 03/2013
1	Interferon-alpha (Interferon Alfa)IBA 08/2012
1	behenic acid (docosanoic acid)IBA 04/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2009
1	Peptides (Polypeptides)IBA 11/2009
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2009
1	peginterferon alfa-2a (Pegasys)FDA Link 03/2008
1	Vitamin K FDA Link 05/2006

Therapy/Procedure

11	Liver Transplantation 01/2019 - 07/2005
8	Therapeutics 01/2022 - 07/2005
3	Transplantation 04/2013 - 02/2009
1	Drug Therapy (Chemotherapy) 01/2021
1	Fontan Procedure (Fontan Operation) 01/2018
1	Hepatic Portoenterostomy 03/2016
1	Immunomodulation 03/2013
1	Aftercare (After-Treatment) 08/2012
1	Sutures (Suture) 10/2010